Leng et al. elucidate that dapagliflozin treatment was associated with the inhibition of the secretion of IL-1β by macrophage via the ROS-NLRP3-caspase-1 pathway in atherosclerosis for the first time (136). The gene discussed is NLRP3; the disease is atherosclerosis.